Firebrick Pharma Group caps off $7m IPO
MELBOURNE: Firebrick Pharma, which is developing a nasal spray for common cold, will ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
MELBOURNE: Firebrick Pharma, which is developing a nasal spray for common cold, will ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
